Rang	Name	Position
1	Mr. Christopher Peetz	CEO & Director
2	Mr. Peter Radovich M.B.A., Ph.D.	COO & President
3	Mr. Eric H. Bjerkholt M.B.A., M.S.	Chief Financial Officer
4	Dr. Joanne M. J. Quan M.D.	Chief Medical Officer
5	Dr. Jean-Luc Girardet Ph.D.	Chief Technical Officer
6	Mr. Andrew McKibben	Senior Vice President, Strategic Finance & Investor Relations
7	Mr. Douglas T. Sheehy J.D.	Chief Legal Officer & Secretary
8	Meredith Kiernan	Senior Director of Global Corporate Communications
9	Ms. Erin Campany	Chief People Officer
10	Ms. Lara Longpre MBA, MSC	Chief Development Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Frazier Life Sciences Management, L.P.	11,83%	0,75 Mrd. USD
2	HHG PLC	10,70%	0,68 Mrd. USD
3	BlackRock Inc	5,92%	0,38 Mrd. USD
4	Vanguard Capital Management, LLC	3,72%	0,24 Mrd. USD
5	FMR Inc	3,03%	0,19 Mrd. USD
6	State Street Corp	2,99%	0,19 Mrd. USD
7	T. Rowe Price Associates, Inc.	2,64%	0,17 Mrd. USD
8	Bvf Inc	2,44%	0,16 Mrd. USD
9	Vanguard Portfolio Management, LLC	2,21%	0,14 Mrd. USD
10	William Blair Investment Management, LLC	2,16%	0,14 Mrd. USD
11	Novo A/S	2,04%	0,13 Mrd. USD
12	Wellington Management Company LLP	2,02%	0,13 Mrd. USD
13	Geode Capital Management, LLC	1,94%	0,12 Mrd. USD
14	Eventide Asset Management, LLC	1,92%	0,12 Mrd. USD
15	TANG CAPITAL MANAGEMENT LLC	1,90%	0,12 Mrd. USD
16	Capital World Investors	1,78%	0,11 Mrd. USD
17	TCG Crossover Management, LLC	1,64%	0,10 Mrd. USD
18	BNP Paribas Arbitrage, SA	1,40%	0,09 Mrd. USD
19	Rock Springs Capital Management LP	1,23%	0,08 Mrd. USD
20	Bank of America Corp	1,11%	0,07 Mrd. USD